IL1B and metabolic syndrome: I/R conditions promoted an increase in the concentrations of these variables from Ct and MetS rats and the 7-day clofibrate pre-treatment prevented this increase in the same proportion in the experimental groups (approximately 45% for IL-1β, 30% for IL-6, and 55% for TNF-α).